Concepedia

Yosuke Seto

YS

Statistics

Publications

9

Citations

355

H-Index

9

Active since

2014

Affiliations

Japanese Foundation For Cancer Research(Current)

The University of Tokyo

The Cancer Institute Hospital

Kyoto University

Yosuke Seto is an author at Japanese Foundation For Cancer Research specializing in natural sciences, biology, and tumor biology.

ORCID

Top concepts

Publications per year

2014–2021

9

Publications

9

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Ryohei Katayama, Bo Gong, Noriko Togashi et al. · Nature Communications · 2019 · 135 citations · Full text

Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation

Ray Sagawa, Seiji Sakata, Bo Gong et al. · JCI Insight · 2021 · 46 citations · Full text

, , +21

Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis

Satoshi Takagi, Yuki Sasaki, Sumie Koike et al. · Oncogene · 2021 · 44 citations · Full text

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

K. Takahashi, Yosuke Seto, Koutaroh Okada et al. · Thoracic Cancer · 2020 · 36 citations · Full text

The Wide Distribution and Change of Target Specificity of R2 Non-LTR Retrotransposons in Animals

Kenji K. Kojima, Yosuke Seto, Haruhiko Fujiwara · PLoS ONE · 2016 · 27 citations · Full text

1–5 of 9